Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 307
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06630260 | 5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours | ||
| NCT02310997 | Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT) | ||
| NCT03328247 | Achieving Self-directed Integrated Cancer Aftercare (ASICA) in Melanoma | ||
| NCT05097625 | Head and Neck Early Relapse Detection Study (HERD) | ||
| NCT02752204 | An Evaluation AZD2014 Alone and in Combination With Rituximab in Relapsed/Refractory Diffuse Large B Cell Lymphoma | ||
| NCT01390571 | Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma | ||
| NCT03177187 | Combination Study of AZD5069 and Enzalutamide. | ||
| NCT05554523 | How Does Skin Tone Affect Quantitative Photoacoustic Imaging | ||
| NCT01212887 | Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer | ||
| NCT03145961 | A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients | ||
| NCT00112931 | Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma | ||
| NCT06632236 | 5G-EMERALD: Amivantamab in Malignant Brain Tumours | ||
| NCT01118611 | Aurora B/C Kinase Inhibitor GSK1070916A in Treating Patients With Advanced Solid Tumors | ||
| NCT03466034 | The Role of Hypoxia as a Selective Pressure for TP53 Mutations | ||
| NCT01881386 | Lactate Imaging as a Tumour Biomarker | ||
| NCT01791595 | A Phase I Trial of AZD3965 in Patients With Advanced Cancer | ||
| NCT00261456 | The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer | ||
| NCT01941849 | Phase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and Paraganglioma | ||
| NCT02583542 | A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers | ||
| NCT05097274 | The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation. | ||
| NCT00900289 | Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer | ||
| NCT04226937 | DLBCL Interim Response Evaluation for Customised Therapy | ||
| NCT07279454 | The EAT-FIBRE Study. | ||
| NCT02695966 | EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary Pancreatic Cancer | ||
| NCT02540928 | AMG 319 in HPV Positive and Negative HNSCC | ||
| NCT00532194 | An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian Cancer | ||
| NCT00959231 | Donor Umbilical Cord Blood Transplant After Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease | ||
| NCT03096054 | A Phase I Trial of LY3143921 Hydrate in Solid Tumours | ||
| NCT03024580 | A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer | ||
| NCT02417662 | Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer | ||
| NCT03327662 | Utilising CTC Counts to Optimize Systemic Therapy of Metastatic Prostate Cancer | ||
| NCT01505829 | Diffusion-weighted Imaging Study in Cancer of the Ovary | ||
| NCT00554775 | WBRT & Erlotinib in Advanced NSCLC and Brain Metastases | ||
| NCT05635344 | A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia | ||
| NCT01263171 | Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by Surgery | ||
| NCT01147029 | GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to Therapy | ||
| NCT02124369 | Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE) | ||
| NCT00967954 | Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer | ||
| NCT02741856 | Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation | ||
| NCT01810757 | Study of Weekly Radiotherapy for Bladder Cancer | ||
| NCT00720447 | Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma | ||
| NCT00411138 | Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer | ||
| NCT05361135 | 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia | ||
| NCT01196741 | Saracatinib and Paclitaxel in Platinum-resistant Ovarian Cancer | ||
| NCT02403102 | Imageguided Theranostics in Multiple Myeloma | ||
| NCT00757991 | Blood Samples From Healthy Volunteers for Genetic Studies in the East Anglia Region of the United Kingdom | ||
| NCT07209774 | Healthspan Connect Programme of Research | ||
| NCT06529718 | Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients | ||
| NCT00072462 | Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ | ||
| NCT01791985 | AZD4547 & Anastrozole or Letrozole (NSAIs) in ER+ Breast Cancer Patients Who Have Progressed on NSAIs (RADICAL) |
